| Literature DB >> 35716398 |
Chiara Muzzana1, Franco Mantovan1,2, Markus Karl Huber2, Katia Trevisani1, Sarah Niederbacher2, Alexander Kugler2, Dietmar Ausserhofer1.
Abstract
AIM: To describe the incidence, time in days and risk factors for postoperative delirium in elderly patients.Entities:
Keywords: delirium; general surgery; nursing assessment; outcome assessment health care; postoperative complications; postoperative delirium
Mesh:
Year: 2022 PMID: 35716398 PMCID: PMC9374408 DOI: 10.1002/nop2.1263
Source DB: PubMed Journal: Nurs Open ISSN: 2054-1058
FIGURE 1Patient flow chart
Socio‐demographic and pre‐operative characteristics of the sample and associations with postoperative delirium
| Pre‐operative variables | Total Sample ( | With POD ( | Without POD ( |
| Bivariate logistic regression | OR | 95% CI |
|
|---|---|---|---|---|---|---|---|---|
| % ( | % ( | % ( | ||||||
| Gender | ||||||||
| Male | 48.8 (98) | 73.3 (11) | 46.8 (87) | |||||
| Female | 51.2 (103) | 26.7 (4) | 53.2 (99) | .05 Pe | Female | 0.32 | 0.09–1.04 | .05 |
| Age (in years) | ||||||||
| 65–79 years | 73.5 (147) | 33.3 (5) | 76.8 (142) | |||||
| ≥80 years | 26.5 (53) | 66.7 (10) | 23.2 (43) | .001 Fi | Age ≥80 years | 6.60 | 2.14–20.37 | .001 |
| Reason of admission | ||||||||
| Prosthesis LL/UL | 51.0 (102) | 46.7 (7) | 51.1 (95) | Prosthesis LL/UL | 1.19 | 0.41–3.42 | .74 | |
| Surgery for malignant tumour –abdominal | 13.4 (27) | 26.7 (4) | 12.4 (23) | Surgery for malignant tumour –abdominal | 0.39 | 0.11–1.32 | .13 | |
| Other surgery‐ abdominal | 10.4 (21) | 13.3 (2) | 10.2 (19) | Other surgery‐ abdominal | 0.74 | 0.15–3.52 | .70 | |
| Fracture and rupture | 12.9 (26) | 13.3 (2) | 12.9 (24) | Fracture and rupture | 0.96 | 0.20–4.53 | .96 | |
| Other | 12.4 (25) | 0 | 13.5 (25) | .50 | Other | |||
| Ward of admission | ||||||||
| Trauma surgery/orthopedy | 72.3 (146) | 60.0 (9) | 73.1 (137) | Trauma surgery/orthopedy | 0.55 | 0.18–1.62 | .28 | |
| General surgery | 27.7 (56) | 40.0 (6) | 26.9 (50) | .27 | ||||
| BRASS score | ||||||||
| ≤10 | 88.5 (177) | 80.0 (12) | 89.2 (165) | |||||
| ≥11 | 11.5 (23) | 20.0 (3) | 10.8 (20) | .29 | BRASS score ≥11 | 2.06 | 0.53–7.93 | .29 |
| Functional status | ||||||||
| Indipendent in ADL and IADL | 72.6 (146) | 60.0 (9) | 73.7 (137) | |||||
| Dependant in one or more ADL/IADL | 27.4 (55) | 40.0 (6) | 26.3 (49) | .24 | Dependant in one or more ADL/IADL | 1.86 | 0.63–5.50 | .26 |
| Mobility | ||||||||
| Ambulatory | 66.8 (135) | 46.7 (7) | 68.8 (128) | |||||
| Ambulatory with mechanical | 27.7 (55) | 46.7 (7) | 25.8 (48) | .22 | Ambulatory with mechanical | 2.67 | 0.88–8.00 | .08 |
| Sensory deficits | ||||||||
| None | 56.2 (113) | 53.3 (8) | 56.5 (105) | |||||
| Visual or hearing deficits | 36.8 (74) | 46.7 (7) | 36.0 (67) | .81 | Sensory deficits | 1.13 | 0.39–3.25 | .81 |
| Number active medical problems | ||||||||
| More than trhee medical problems | 37.9 (85) | 60.0 (9) | 42.2 (76) | .12 | ||||
| Number of drugs | ||||||||
| Fewer than 3 | 40.1 (81) | 26.7 (4) | 41.4 (77) | |||||
| 3–5 | 36.8 (74) | 26.7 (4) | 37.6 (70) | 3–5 drugs | 1.10 | 0.26–4.56 | .89 | |
| More than 5 | 22.8 (46) | 46.7 (7) | 21.0 (39) | .07 | More than 5 | 3.45 | 0.95–12.51 | .06 |
| Psychotropic drugs | 26.2 (52) | 40.0 (6) | 27.4 (46) | .22 | Psycotropic drugs | 2.03 | 0.68–6.00 | .20 |
| Comorbidity | ||||||||
| 0 disease | 21.4 (43) | 6.7 (1) | 22.6 (42) | |||||
| 1–2 disease | 58.7 (118) | 53.3 (8) | 59.1 (110) | 1–2 disease | 3.05 | 0.37–25.17 | .29 | |
| ≥3 diesease | 19.9 (40) | 40.0 (6) | 18.3 (34) | .08 | ≥3 diesease | 7.41 | 0.85–64.57 | .07 |
| Arterial ipertension | 57.7 (115) | 66.7 (10) | 56.8 (105) | .59 | Arterial ipetrtension | 1.52 | 0.50–4.63 | .46 |
| Hearth failure | 33.3 (67) | 60.0 (9) | 31.4 (58) | .02 | Hearth failure | 3.28 | 1.11–9.65 | .03 |
| Tumour | 15.9 (32) | 26.7 (4) | 15.1 (28) | .26 | Tumour | 2.04 | 0.60–6.85 | .25 |
Abbreviations: ADL, Activities of Daily Living; BRASS, Blaylock Risk Assessment Screening Score; Fi, Fisher; IADL, Instrumental Activities of Daily Living; Pe, Pearson; Prosthesis LL/UL, Lower Limbs/Upper Limbs.
Surgery in non abdominal district and other orthopaedic surgeries.
FIGURE 2Number of positive assessments by postoperative days in patients diagnosed with POD (N = 15)
Intra‐ and postoperative characteristics of the patient sample and associations with postoperative delirium
| Variables | Total sample ( | With POD ( | Without POD ( |
| Bivariate regression | OR | 95% CI |
|
|---|---|---|---|---|---|---|---|---|
| % ( | % ( | % ( | ||||||
|
| ||||||||
| Median time pre‐surgery (in hours) | ||||||||
| <24.5 hr | 49.8 (100) | 53.3 (8) | 49.5 (92) | |||||
| ≥24.5 hr | 50.2 (101) | 46.7 (7) | 50.5 (94) | .80 | ||||
| Urgency of surgery | ||||||||
| Elective | 86.6 (174) | 73.3 (11) | 87.6 (163) | |||||
| Urgent | 13.4 (27) | 26.7 (4) | 12.4 (23) | .12 | Urgent | 2.57 | 0.75–8.77 | .13 |
| Type of surgery | ||||||||
| Laparoscopy | 14.5 (29) | 6.7 (1) | 15.1 (28) | Laparotomy | 2.49 | 0.31–19.75 | .38 | |
| Laparotomy | 85.5 (171) | 93.3 (14) | 84.9 (157) | .70 | ||||
| ASA classification | ||||||||
| I–II | 80.0 (160) | 60.0 (9) | 81.6 (151) | |||||
| III–IV | 20.0 (40) | 40.0 (6) | 18.4 (34) | .84 | ASA III‐ IV | 2.96 | 0.98–8.87 | .05 |
| General anaesthesia | ||||||||
| Yes | 51.2 (103) | 53.3 (8) | 51.1 (95) | General (vs other) | 3.14 | 0.86–1.09 | .38 | |
| No | 48.8 (98) | 46.7 (7) | 48.9 (91) | .26 | ||||
| Intraoperative drugs | ||||||||
| Opioids | 95.9 (186) | 93.3 (14) | 96.1 (172) | .48 | Opioids | 0.56 | 0.06–4.96 | .61 |
| Benzodiazepines | 11.9 (23) | 20.0 (3) | 11.2 (20) | .39 | Benzodiazepines | 1.98 | 0.51–7.65 | .31 |
| Ketamina | 100 (194) | 100 (15) | 100 (179) | – | ||||
| Post anaesthesia care unit drugs | ||||||||
| Opioids | 38.3 (69) | 50.0 (6) | 37.5 (63) | .54 | Opioids | 1.66 | 0.51–5.39 | .39 |
| Benzodiazepinas | 0.6 (1) | 0 | 0.6 (1) | 1.00 | ||||
| Ketamina | 0.5 (1) | 0 | 0.6 (1) | 1.00 | ||||
|
| ||||||||
| Surgical drains | ||||||||
| Yes | 53.2 (107) | 80.0 (12) | 51.1 (95) | Surgical drain‐s | 3.83 | 1.04–14.02 | .04 | |
| No | 46.8 (94) | 20.0 (3) | 48.9 (91) | .031 Pe | ||||
| Bladder catheter | ||||||||
| Yes | 33.3 (67) | 66.7 (10) | 30.6 (57) | Bladder catheter | 4.52 | 1.48–13.84 | .008 | |
| No | 66.7 (134) | 33.3 (5) | 69.4 (129) | .004 P | ||||
| Peripheral venous catheter | ||||||||
| Yes | 97.5 (196) | 93.3 (14) | 97.8 (182) | |||||
| No | 2.5 (5) | 6.7 (1) | 2.2 (4) | .32 | ||||
| Central venous catheter or PICC | ||||||||
| Yes | 15.4 (31) | 40.0 (6) | 13.4 (25) | Central venous catheter or PICC | 4.29 | 1.40–13.10 | .01 | |
| No | 84.6 (170) | 60.0 (9) | 86.6 (161) | .015 Fi | ||||
| Other devices | ||||||||
| Yes | 64.2 (129) | 93.3 (14) | 61.8 (115) | Other devices | 8.64 | 1.11–67.15 | .03 | |
| No | 35.8 (72) | 6.7 (1) | 38.2 (71) | .014 Pe | ||||
| Unplanned intensive care unit‐ admission | ||||||||
| Yes | 8.0 (16) | 13.3 (2) | 7.5 (14) | |||||
| No | 92.0 (185) | 86.7 (13) | 92.5 (172) | .25 | ||||
| Postoperative pain | ||||||||
| Yes | 69.8 (139) | 85.7 (12) | 68.6 (127) | Postoperative pain | 2.74 | 0.59–12.63 | .19 | |
| No | 30.2 (60) | 14.3 (2) | 31.4 (58) | .23 | ||||
| PONV | ||||||||
| Yes | 10.1 (20) | 6.7 (1) | 10.3 (19) | |||||
| No | 89.9 (179) | 93.3 (14) | 89.7 (165) | 1.00 | ||||
| Blood trasfusion | ||||||||
| Yes | 14.1 (28) | 26.7 (4) | 13.0 (24) | |||||
| No | 85.9 (171) | 73.3 (11) | 87.0 (160) | .23 | ||||
Abbreviations: Fi, Fisher; Pe, Pearson; PONV, Postoperative Nausea and Vomiting.
Oxygen therapy device, nasogastric tube, peridural catheter.
Episode NRS ≥3.